MedTrace Logo

Hydrocolloid Dressings in Diaper Dermatitis

NCT07186907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-09-22

No results posted yet for this study

Summary

Diaper dermatitis (commonly known as diaper rash) is one of the most frequent skin problems in newborns and infants, especially in neonatal intensive care units (NICUs). This study was designed to compare two treatment approaches for diaper dermatitis: hydrocolloid dressings and a cream containing 40% zinc oxide. The severity of diaper rash was evaluated at the beginning of treatment and at 24, 48, and 72 hours of follow-up.

Conditions

  • Diaper Dermatitis
  • Diaper Dermatitis Healing
  • Diaper Rash

Interventions

DEVICE

Hydrocolloid dressing

Hydrocolloid dressing was used for diaper dermatitis

DRUG

Zinc oxide cream %40

Zinc oxide cream was used in diaper dermatitis.

Sponsors & Collaborators

  • Gozde AKSUCU

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
0 Days
Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-13
Primary Completion
2018-03-13
Completion
2018-03-17

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07186907 on ClinicalTrials.gov